12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

HGH-CTP: Extension study data

Top-line data from 42 patients who were well titrated on a daily hGH therapy in a 4-month extension study of an open-label, dose-ranging, international Phase II trial showed that once-weekly injection of hGH-CTP led to average IGF-1 levels that were within the normal therapeutics range, +/- 2 standard deviations from the average IGF-1 levels expected in a normal population, in 88% of...

Read the full 288 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >